Product Information
LEUPROLIDE 2WK 14 MG/2.8 ML KT is a generic product labeled by NorthStar Rx LLC, priced at $205.7080 per EA under NDC 72603034401. Its NADAC has been published 95 times since Jul 10, 2024.
FDA first approved this application on Aug 13, 2021. Its Orange Book therapeutic-equivalence code is AP.
Manufacturer
NorthStar Rx LLCNDC
72603034401
Classification
Generic
Dosage Form
KIT
Route
SUBCUTANEOUS
Effective Date
4/22/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA213829FDA Approved
8/13/2021
TE Code
AP
On Market Since
3/1/2024
Price Statistics
The NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has been published 95 times since Jul 10, 2024, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $205.7080 per EA |
|---|---|
| All-time high | $301.8717 (Sep 10, 2025) |
| All-time low | $205.7080 (Apr 22, 2026) |
| 52-week high | $301.8717 |
| 52-week low | $205.7080 |
| Median price | $261.3184 |
| Average price | $265.9364 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 95 |
| Tracking since | Jul 10, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
-15.5%
1Y
-31.9%
3Y
N/A
5Y
N/A
All
-10.7%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEUPROLIDE 2WK 14 MG/2.8 ML KT?
The current National Average Drug Acquisition Cost (NADAC) for LEUPROLIDE 2WK 14 MG/2.8 ML KT, manufactured by NorthStar Rx LLC, is $205.7080 per EA (NDC 72603034401), effective Apr 29, 2026.
How has the price of LEUPROLIDE 2WK 14 MG/2.8 ML KT changed over time?
Over the history we have for it, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has declined 10.7%. It has been tracked across 95 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Since Jul 10, 2024, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has ranged from a low of $205.7080 (Apr 22, 2026) to a high of $301.8717 (Sep 10, 2025), with a median of $261.3184 per EA.
Are there cheaper alternatives to LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEUPROLIDE 2WK 14 MG/2.8 ML KT, is $197.6060 per EA — about 4% below LEUPROLIDE 2WK 14 MG/2.8 ML KT.
Who manufactures LEUPROLIDE 2WK 14 MG/2.8 ML KT?
LEUPROLIDE 2WK 14 MG/2.8 ML KT (NDC 72603034401) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.